Literature DB >> 9182920

The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis.

H Okamoto1, M Yamamura, Y Morita, S Harada, H Makino, Z Ota.   

Abstract

OBJECTIVE: To determine the expression of interleukin-6 (IL-6), IL-11, leukemia inhibitory factor (LIF), and oncostatin M (OSM) and their major cellular sources in the joints of rheumatoid arthritis (RA) patients, as well as the correlation of circulating levels of these IL-6-type cytokines and C-reactive protein (CRP).
METHODS: Messenger RNA (mRNA) and protein levels for IL-6, IL-11, LIF, and OSM were determined by using reverse transcription-polymerase chain reaction and enzyme-linked immunosorbent assay, respectively.
RESULTS: Cells isolated from the synovium of RA patients expressed mRNA for IL-6, IL-11, LIF, and OSM at higher levels than did synovial cells from osteoarthritis (OA) patients, and spontaneously released greater quantities of these proteins in culture. Fibroblast cell lines derived from RA synovium were able to produce IL-6, IL-11, and LIF, but not OSM, when stimulated with IL-1 and tumor necrosis factor alpha. OSM was found to be produced spontaneously by synovial tissue macrophages. IL-6, IL-11, LIF, and OSM were present in synovial fluid from the RA patients; levels of IL-6, LIF, and OSM were present in significantly greater quantities in RA patients than in OA patients. However, only IL-6 was significantly elevated in the serum of RA patients and correlated with the serum CRP level, while other IL-6-type cytokines were not detected.
CONCLUSION: IL-6, IL-11, LIF, and OSM are all produced in large amounts at the site of disease activity, but IL-6 derived from synovial fibroblasts may be the major hormone-like mediator that induces the hepatic synthesis of acute-phase proteins in RA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9182920     DOI: 10.1002/art.1780400614

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  71 in total

1.  Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo.

Authors:  C Langdon; C Kerr; M Hassen; T Hara; A L Arsenault; C D Richards
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

Review 2.  Inflammatory bone loss: pathogenesis and therapeutic intervention.

Authors:  Kurt Redlich; Josef S Smolen
Journal:  Nat Rev Drug Discov       Date:  2012-03-01       Impact factor: 84.694

3.  K/B×N serum transfer arthritis is delayed and less severe in leukaemia inhibitory factor (LIF)-deficient mice.

Authors:  A Upadhyay; D Senyschyn; L Santos; R Gu; G J Carroll; J A Jazayeri
Journal:  Clin Exp Immunol       Date:  2012-08       Impact factor: 4.330

4.  Osteoblasts and stromal cells isolated from femora in rheumatoid arthritis (RA) and osteoarthritis (OA) patients express IL-11, leukaemia inhibitory factor and oncostatin M.

Authors:  G Lisignoli; A Piacentini; S Toneguzzi; F Grassi; B Cocchini; A Ferruzzi; G Gualtieri; A Facchini
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

5.  Chlorogenic acid induces apoptosis to inhibit inflammatory proliferation of IL-6-induced fibroblast-like synoviocytes through modulating the activation of JAK/STAT and NF-κB signaling pathways.

Authors:  Lixia Lou; Jingwei Zhou; Yujun Liu; Y I Wei; Jiuli Zhao; Jiagang Deng; Bin Dong; Lingqun Zhu; Aiming Wu; Yingxi Yang; Limin Chai
Journal:  Exp Ther Med       Date:  2016-03-09       Impact factor: 2.447

Review 6.  The roles of catabolic factors in the development of osteoarthritis.

Authors:  Dominick J Blasioli; David L Kaplan
Journal:  Tissue Eng Part B Rev       Date:  2013-12-11       Impact factor: 6.389

7.  Effects of high-dose corticosteroids on post-traumatic inflammatory mediators.

Authors:  Olav Reikerås; Arthur Helle; Claus Danckert Krohn; Jens Ivar Brox
Journal:  Inflamm Res       Date:  2009-06-28       Impact factor: 4.575

Review 8.  Cytokine therapy in rheumatoid arthritis.

Authors:  J Hermann; M Walmsley; F M Brennan
Journal:  Springer Semin Immunopathol       Date:  1998

Review 9.  Production of interleukin-6 by synovial fibroblasts in rheumatoid arthritis.

Authors:  H Baumann; I Kushner
Journal:  Am J Pathol       Date:  1998-03       Impact factor: 4.307

10.  The correlation between increased serum concentrations of interleukin-6 family cytokines and disease activity in rheumatoid arthritis patients.

Authors:  Soo-Jin Chung; Yong-Jin Kwon; Min-Chan Park; Yong-Beom Park; Soo-Kon Lee
Journal:  Yonsei Med J       Date:  2011-01       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.